Nektar Therapeutics
NKTR
#4555
Rank
โ‚น243.14 B
Marketcap
โ‚น7,197
Share price
0.85%
Change (1 day)
265.63%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -โ‚น748.92

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น802.59. In 2025 the company made an earnings per share (EPS) of -โ‚น972.26 a decrease over its 2024 EPS that were of -โ‚น844.54.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น748.92-22.97%
2025-โ‚น972.2615.12%
2024-โ‚น844.54-59.54%
2023-โ‚น2,088-25.89%
2022-โ‚น2,817-31.12%
2021-โ‚น4,08914.86%
2020-โ‚น3,560-1.19%
2019-โ‚น3,603-163.96%
2018โ‚น5,633-725.4%
2017-โ‚น900.77-42.73%
2016-โ‚น1,57383.33%
2015-โ‚น857.8839.53%
2014-โ‚น614.81-69.29%
2013-โ‚น2,002-6.67%
2012-โ‚น2,145

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น832.59-203.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น124.87-115.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,380-271.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น203.03-74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.76-142.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น662.47-182.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น25.74-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น88.65-111.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland